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In recent years, the production of customized medical implants through
additive manufacturing by the Centre for Rapid Prototyping and Manufac-
turing in South Africa has grown significantly. While satisfactory results have
been obtained and the quality of life of many patients has been improved,
further research is required to enable the production of qualified components.
This paper shares the growing acceptance of additive manufacturing, as well
as the establishment of a South African Additive Manufacturing Strategy. An
overview of the progress made by the Collaborative Programme in Additive
Manufacturing is presented. The scope of the metals research performed to-
wards the qualification of additive manufacturing of Ti6Al4V medical im-
plants is discussed. Examples are given of internationally leading work on
utilizing these implants, which were additively manufactured under an ISO
13485 system, in maxillofacial reconstructive surgery. Lastly, the develop-
ment of an affordable polyurethane artificial heart valve is presented as a
different type of medical implant.
INTRODUCTION
In 2015, Richard D’Aveni stated in an article in
Harvard Business Review: ‘‘Industrial 3-D printing
is at a tipping point, about to go mainstream in a big
way.’’1 This has indeed become a reality since 2015,
and additive manufacturing (AM) has been accepted
as a key technology of the 4th Industrial Revolution,
also known as Industry 4.0. Over the past decade,
since the first prototypes, the production of cus-
tomized medical implants through AM of Ti6Al4V
(ELI) in South Africa has been growing strongly.2
Through the collaboration between engineers of the
Centre for Rapid Prototyping and Manufacturing
(CRPM) of the Central University of Technology,
Free State (CUT) in Bloemfontein, South Africa,
and leading prosthodontic, maxillofacial and ortho-
pedic surgeons the quality of life of many patients
has been restored. Patients whose faces had been
disfigured through cancerous tumors gained
renewed acceptance in their communities after
reconstructive surgery to restore their features
and functions through customized titanium alloy
implants.3 While the CRPM engineers in collabora-
tion with surgeons pushed ahead with cutting-edge
work on customizing Ti6Al4V (ELI) implants for
various skeletal reconstruction needs, it was real-
ized by the AM community that, for full qualifica-
tion of such implants, significant research was
required. Qualification of the materials used in
AM,4 as well as the AM process chain,5 was
essential for acceptance by not only the medical
industry but also by aerospace.
During 2013 and 2014, the South African Depart-
ment of Science and Technology commissioned the
development of an AM Technology Roadmap for the
country. The outcome of this process was the
publication of the South African Additive Manufac-
turing Strategy in August 2015.6 This document
serves as guide to South African and international
players in identifying economic opportunities,
addressing technology gaps, focusing on develop-
ment programmes and informing investment deci-
sions that would eventually enable local companies
and industry sectors to become global leaders in
selected areas of AM.7 One of the four main priority
focus areas of this South African AM Strategy was
research and development towards qualified AM
technology for final part manufacturing for the
medical and aerospace markets.6
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In a pro-active response to the recommendations
of the SA AM Strategy, research leaders from South
African universities involved in AM [CUT, Stellen-
bosch University (SU), Vaal University of Technol-
ogy (VUT) and North West University (NWU)] in
collaboration with the National Laser Centre (NLC)
at the Council for Scientific and Industrial Research
(CSIR) and a leading aerospace manufacturer,
Aerosud, developed and aligned the Collaborative
Program in Additive Manufacturing (CPAM) with
the priority focus areas of this strategy. A relevant
sub-program of the CPAM is titled Qualification of
Additive Manufacturing of Ti6Al4V for Medical
Implants and Aerospace Components. The institu-
tions collaborating with CUT in this sub-pro-
gramme are SU, University of Cape Town (UCT),
NWU, NLC and CSIR.
In support of the drive towards commercialization
of medical implants and devices, an ISO 13485
quality management system was successfully estab-
lished in the CRPM at CUT. To comply with the
requirements of this quality management system, an
EOSINT M280 DMLS machine is dedicated exclu-
sively to the AM of Ti6Al4V (ELI) medical implants.
The system was audited by TÜV in February 2016
and certification of the CUT-CRPM was officially
awarded on 20 June 2016. The scope of this certifi-
cation supports commercialization as follows:
 Design, development and production of patient
specific custom-made titanium implants by
means of 3D printing/AM.
 Design, development and production of patient
specific custom-made preoperative models, jigs,
cutting guides in nylon by means of 3D printing/
AM.
 Contract production of titanium implants by
means of 3D printing/AM.
 Contract production of preoperative models, jigs,
cutting guides in nylon by means of 3D printing/
AM.
Although this quality management system provided
the framework for ensuring the reliability and
repeatability of the AM performed at the CRPM,
the generation of data to validate the individual
processes in the AM process chain had become
imperative. Sufficient research data had to be
produced and published to prove that parts pro-
duced through AM can fully comply with the
accepted international standards for the material,
physical, chemical and mechanical properties of
such parts. To achieve this, a process chain for the
qualification of medical implants was developed, as
shown in Fig. 1. This diagram indicates the differ-
ent areas (yellow blocks) where the CPAM research
projects are focused to generate the data and
establish the techniques and processes that will
underpin the qualification procedures.
RESEARCH IN SUPPORT OF QUALIFICA-
TION
Research topics that are being investigated
towards full qualification of medical implants
include:
 Characterization of Ti6Al4V (ELI) powder and
monitoring of powder re-use.
 Evaluation of the microstructure of Ti6Al4V
(ELI) as a function of AM build parameters.
 Residual stress analysis through x-ray and neu-
tron diffraction.
 Establishment of stress-relieving heat treat-
ments.
 Development of heat treatments to obtain de-
sired mechanical and fatigue properties.
 Determination of fatigue properties as-built and
after high-temperature annealing heat treat-
ments.
 High strain rate performance of direct metal
laser sintering (DMLS) Ti6Al4V (ELI) parts.
 High-velocity impact properties of DMLS
Ti6Al4V (ELI) parts.
 Non-destructive evaluation of AM part integrity.
 Multi-material titanium-based structures
through in situ alloying.
Two of the research projects in these focus areas are
discussed in more detail here.
Fig. 1. Research areas in the additive manufacturing process chain
for qualification of medical implants.
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Characterisation and Monitoring of Ti6Al4V
(ELI) Powder
The full description of the methodology followed
to characterize the virgin as-received powder and
monitor the powder properties after repeated re-use
is given in Thejane et al.8 and in Thejane.9 In this
study, Ti6Al4V (ELI) powder with differing particle
size distributions, used in two different selective
laser melting (SLM) systems, were studied. It was
found that the powder used in the DMLS system,
which was operated in the ISO 13485 quality
management environment, could be re-used indef-
initely, provided it was topped up with virgin
powder to maintain the required levels on the
machine’s build platform. Even after 35 build cycles,
the chemical composition of the powder still com-
plied with the ASTM F3001-14 standard.10 The
powder morphology also displayed no significant
changes on repeated re-use, as can be seen in Fig. 2.
The particle size distribution (PSD) of the virgin
powder was determined by micro-CT scanning and
laser diffraction, while the PSD of this powder after
the different re-use cycles was determined by laser
diffraction. From the laser diffraction results (see
Fig. 3), it was clear that negligible changes occurred
in the particle size distribution, and after 35 build
cycles it still complied with the requirement for the
machine.
In addition, the internal porosity of individual
particles was determined by micro-CT scanning,
using a technique described by du Plessis et al.11
The volume fraction of porosity in the DMLS
powder was found to be negligibly small (between
0.00% and 0.01%).
From this study,9 it was concluded that Ti6Al4V
(ELI) powder quality can be effectively established
and monitored through a range of tests performed to
international standards. Provided a quality man-
agement system is maintained, the unused Ti6Al4V
(ELI) powder in a DMLS system can be re-used
until fully consumed.
High Cycle Fatigue Properties of As-Built
and Heat-Treated Ti6Al4V (ELI) Specimens
As part of an investigation to generate data on the
fatigue properties of Ti6Al4V (ELI) parts built
through DMLS, Malefane et al.12 determined the
fatigue properties of as-built specimens. Rectangu-
lar bars were built in the three orthogonal (X-, Y-
and Z-) build directions (the X-axis was aligned with
the direction of movement of the powder re-coater of
the EOSINT M280 machine). No stress-relieving
heat treatment was applied to these specimens. The
bars were machined and polished to standard
fatigue specimen geometry (ASTM E466 and ISO
1099). For the tension–tension fatigue tests, the
following fatigue test parameters were applied: A
50-kN Instron 1342, axial, servo-hydraulic machine
was used. An R-ratio of 0.1 was used with a cycling
frequency of 10 Hz. The tests were executed at an
environmental temperature of 20 ± 2C. As run-
out, 5 9 106 cycles was accepted.
Fig. 2. Scanning electron micrographs of the Ti6Al4V (ELI) powder used in the EOSINT M280 DMLS machine as received (virgin) and after
various re-use cycles. Scale bar 50 lm. Magnification 9 500. Reprinted with permission from Ref. 8.
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The semi-log graphs of maximum stress (S) (MPa)
against life (N) of the specimens produced along the
three orthogonal build directions were plotted and
the displayed endurance limits were compared, as
shown in Fig. 4.
From the run-out levels in Fig. 4, the following
estimated fatigue endurance limits were found: X-
built specimens: 450 MPa; Y- and Z-built speci-
mens: 486 MPa. This difference between the build
directions were considered to be statistically
insignificant, given the spread of the data points.
(Linear curve fitting for the fractured as-built
specimens gave an average correlation coefficient
R =  0.639.)
More recently tension–tension fatigue tests, with
the same fatigue test parameters as those used for
the as-built specimens, were performed by Malefane
et al.13 on Ti6Al4V (ELI) DMLS specimens that
were stress-relieved at 650C for 3 h and subse-
quently annealed at 950C for 2 h. For these
specimens, the estimated fatigue endurance limits
were: X-built specimens: 450 MPa; Y-built speci-
mens: 450 MPa; Z-built specimens: 486 MPa. How-
ever, a smaller scatter of data points was observed,
indicating more consistent fatigue behavior due to
improved ductility of these specimens. (Linear curve
fitting for the fractured as-built specimens gave an
average correlation coefficient R =  0.779.) The
beneficial effect of the high-temperature anneal was
confirmed in a recent study by Yadroitsev et al.14
It should be noted that neither the as-built
specimens nor the stress-relieved and annealed
specimens were submitted to hot isostatic pressing
before the fatigue testing.
Fig. 3. Particle size distribution of the Ti6Al4V (ELI) powder after increasing numbers of re-use cycles in the EOSINT M280 DMLS system.
Reprinted with permission from Ref. 9.




Additive Manufacturing for Facial Recon-
struction
In the Kimberley Hospital Complex in South
Africa, doctors successfully performed the country’s
first 3D-printed jaw bone implantation.15 The
patient, a 31-year-old man, was suffering from
facial disfigurement due to cancer. The surgery to
implant a titanium jaw was headed by Dr. Cules
van den Heever, a prosthodontist, who has exten-
sive experience in prosthetic jaw implantations and
works closely with the CRPM engineers. He was
assisted by Dr. Kobus Hoek, a maxillofacial sur-
geon, as well as doctors at the Kimberley Hospital’s
Dental Department. The implant was intended to
fix the facial contour and restore its normal appear-
ance and function. The customized jaw was
designed (Fig. 5a) and manufactured on site at the
CRPM from Ti6Al4V (ELI) powder in an EOSINT
M280 DMLS machine. The capabilities of the DMLS
technology, such as rapid production of patient-
specific implants, reduction of trauma of the patient
and improved cost-effectiveness of procedures
through shorter surgical theatre time leading to
quicker patient recovery, were demonstrated
through this application.
Based on the confidence levels established with
respect to implant integrity (validation of density,
mechanical properties and fatigue performance
through the data obtained from the various
research projects, as well as the process repeatabil-
ity and part traceability provided by the ISO 13485
system), a next generation of customized mandibu-
lar implant incorporating a cage for bone graft,
shown in Fig. 5b, was designed and implanted
successfully. After full recovery of the patient from
this surgery, bone grafted from the patient was
inserted in the cage and allowed to densify. The
presence of solid bone in the cage to which the
patient’s soft tissue could attach, would offer the
potential to implant dental implants into this bone.
At the time of publication, the implantation of
dental implants had not yet occurred.
Polyurethane Artificial Heart Valve Develop-
ment
Cardiac valve replacement can be with either
biological valves or artificial valves. Biological
valves deteriorate with time, calcify and fail. This
usually requires multiple surgeries. Artificial heart
valves have been developed over the past six to
seven decades and represent one of the most widely
used cardiovascular devices. Some of the existing
devices cause thromboembolic episodes and require
anticoagulation. In developing countries, such as
South Africa, it is not always possible to monitor the
level of anticoagulation properly because interna-
tional normalized ratio clinics are not always in
close proximity to patients, and uncontrolled anti-
coagulation can lead to traumatic internal bleeding
episodes.16 Commercially available mechanical
valves suffer from clotting, while biological alterna-
tives suffer from a short fatigue life. Polyurethane
valves have been perceived as potential means to
address both of the problems of current heart
valves, as well as being biocompatible.16 It was
estimated that the worldwide number of patients
needing heart valve replacement will triple from
290,000 in 2003 to over 850,000 by 2050.17 If an
artificial heart valve, affordable for developing and
emerging economies, could be developed and pro-
duced, the potential for meeting this need could be
significantly improved.
In a collaborative research program between the
CRPM at CUT and the Robert W.M. Frater Cardio-
vascular Research Centre at the University of the
Free State, a reliable, affordable dip-molding
Fig. 5. (a) Initial customised mandibular implant produced through DMLS of Ti6Al4V (ELI) and (b) the next generation mandibular implant with a
cage for bone graft.
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process for repeatable production of tri-leaflet
polyurethane heart valves was developed. DMLS
of Ti6Al4V (ELI) was used for producing the mold
assembly and the valve frame onto which the dip-
molded leaflets attach. This was found to be an
efficient and cost-effective means of expediting the
product development process. A number of proto-
type valves were produced and evaluated with
respect to compliance of properties such as leaflet
thickness, surface finish and mechanical strength.
Pulse duplication trials with these prototypes pro-
vided data on the heart valve pressure drop,
effective orifice area and percentage regurgitation,
as required by the ISO 5840-2:2015 standard.18
Particle imaging velocimetry was employed to mea-
sure the velocity flow field through the heart valve
and to determine the viscous shear stress acting on
the valve. The magnitude of the viscous shear stress
determines the likelihood of hemolysis (damage to
red blood cells) and platelet activation (clotting of
the blood). A prototype polyurethane heart valve
and its functioning during pulse duplication trials
are shown in Fig. 6.
These prototype polyurethane tri-leaflet heart
valves displayed performances that complied at
levels of 80% or better with the ISO 5840-2:2015
standard. Based on the density, mechanical proper-
ties and fatigue performance confirmed through the
research, as well as the process repeatability and
part traceability provided by the ISO 13485 system,
the DMLS produced Ti6Al4V (ELI) heart valve
frames were accepted for this application. This
confirmed that the goal of producing a fully func-
tional, durable and affordable heart valve, capable
of regulating the one-way flow of blood, was indeed
achievable.17
CONCLUSION
The focused research conducted by the partici-
pants in the Collaborative Program in Additive
Manufacturing has been delivering data that are
raising the level of confidence in the ability of well-
managed SLM machines to produce high-quality
medical implants. Characterization and monitoring
of the feedstock Ti6Al4V (ELI) powder can lead to
improved cost-effectiveness of the production pro-
cess through minimizing material wastage and
complete consumption of the material. Through
DMLS process control and appropriate post-process
heat treatment, fatigue properties of components
that compare favorably with those of wrought
Ti6Al4V (ELI) can be achieved. Available research
results have provided strong evidence that there is
no reason to doubt the fit-for-purpose properties of
the medical implants produced under the ISO 13485
quality management system of the CRPM.
However, for full qualification and acceptance of
DMLS-produced components by the aerospace
industry, continued research is required to accumu-
late AM validation data that would satisfy the more
stringent specifications of this sector. For aerospace
applications, hot isostatic pressing of AM parts
would be required at this stage of the technology.
Higher numbers of cycles for acceptable run-out
levels during high cycle fatigue testing will also be
required.
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